PARP1 and neoplasm: For example, PRRT in combination with a poly(ADP-ribose) polymerase-1 (PARP)-inhibitor, checking the DNA repair mechanism, was shown to prolong tumor growth-inhibition and improve the median survival in a preclinical model compared to PRRT alone [70].